Today's briefing covers five breaking science stories: brain connectivity fingerprints that predict cognition, a molecular itch switch, JWST's shocking ice-cloud discovery on an exoplanet, Wisconsin's fusion energy ecosystem, and a single-dose gonorrhea pill clearing phase three trials. Five fields, five developments — all signal, no noise.
Audio is available on Spreaker — see link below.
Your brain has a fingerprint. Not on its surface, but in the way its regions wire together.
Staying with hidden brain and body systems, there's a parallel discovery worth your attention. Researchers have identified a molecule called TRPV4 as what appears to be a neural brake for chronic itch.
Now to space, and a finding that's forcing a rethink of how we model alien atmospheres. The James Webb Space Telescope directly imaged a Jupiter-like exoplanet called Epsilon Indi Ab, and what it found wasn't what the models predicted.
Fusion energy has long been described as perpetually thirty years away. The more honest framing right now is that it's becoming a real commercial question, and Wisconsin is making a deliberate bet on being the answer.
One more development, and it's a practical one. A single-dose oral pill called zoliflodacin has cleared phase three trials for gonorrhea, curing over ninety percent of infections in one dose.
Across today's briefing, the through-line is the same: hidden systems being mapped for the first time, and what that mapping makes possible. Brain wiring as prediction.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.